To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MYO18AandTIAF1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
503 supporting clones for gene MYO18AandTIAF1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
D86970 brain MYO18AandTIAF1.a 1 to 7597 1 to 7597 exact tiling clone, available from KIAA,   7597/7597
(100 %)
0 diff
(100 %id)
BM152556 leukopheresis MYO18AandTIAF1.a 23 to 582 1 to 560       560/561
(99 %)
4 diff
(99.3 %id)
NM_078471.3   MYO18AandTIAF1.a 24 to 7611 1 to 7588 exact RefSeq,   7588/7591
(99 %)
5 diff
(100.0 %id)
CN369685 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells MYO18AandTIAF1.a 29 to 664 1 to 636       636/636
(100 %)
2 diff
(99.7 %id)
CN369686 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells MYO18AandTIAF1.a 53 to 675 1 to 623       623/623
(100 %)
1 diff
(99.9 %id)
AB177858 brain MYO18AandTIAF1.a 205 to 7597 1 to 7393       7393/7393
(100 %)
0 diff
(100 %id)
CV367851 colon_normal MYO18AandTIAF1.a 218 to 421 206 to 5     Submitted on the opposite strand 202/208
(97 %)
0 diff
(100 %id)
AA776190 schizophrenic brain S-11 frontal lobe MYO18AandTIAF1.a 425 to 774 350 to 1       350/350
(100 %)
0 diff
(100 %id)
BG257729 embryonal carcinoma, cell line, testis MYO18AandTIAF1.a 1181 to 1760 1 to 596       596/928
(64 %)
33 diff
(96.5 %id)
DB221646 trachea MYO18AandTIAF1.a 1188 to 1771 2 to 585   capped   584/589
(99 %)
4 diff
(99.4 %id)
BF828143 head_normal MYO18AandTIAF1.a 1268 to 1681 449 to 34     Submitted on the opposite strand 416/485
(85 %)
6 diff
(98.8 %id)
CD635735   MYO18AandTIAF1.a 1910 to 2016 1 to 110       110/123
(89 %)
6 diff
(95.2 %id)
BP307494 brain MYO18AandTIAF1.a 1911 to 2497 1 to 587       587/587
(100 %)
0 diff
(100 %id)
BG988866 head_neck MYO18AandTIAF1.a 2007 to 2388 26 to 415       388/419
(92 %)
25 diff
(94.1 %id)
CN312470 embryonic stem cells, cell lines H1, H7, andH9 MYO18AandTIAF1.a 2053 to 2490 1 to 436       436/436
(100 %)
3 diff
(99.4 %id)
TI_154166857   MYO18AandTIAF1.a 2068 to 2612 78 to 622       545/545
(100 %)
4 diff
(99.3 %id)
BF824940 head_normal MYO18AandTIAF1.a 2230 to 2767 33 to 567       537/573
(93 %)
16 diff
(97.3 %id)
DA094124 cerebellum MYO18AandTIAF1.a 2248 to 2817 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
CU449966 epidermis MYO18AandTIAF1.a 2265 to 2960 701 to 6     Submitted on the opposite strand 696/701
(99 %)
8 diff
(98.9 %id)
CD635727   MYO18AandTIAF1.a 2351 to 3085 11 to 744       734/746
(98 %)
14 diff
(98.2 %id)
BQ354035 head_neck MYO18AandTIAF1.a 2434 to 2685 1 to 252       252/252
(100 %)
4 diff
(98.5 %id)
BF088503 head_neck MYO18AandTIAF1.a 2450 to 2685 1 to 236       236/236
(100 %)
4 diff
(98.4 %id)
AJ133824   MYO18AandTIAF1.a 2488 to 2916 6 to 434       429/434
(98 %)
0 diff
(100 %id)
CD635730   MYO18AandTIAF1.a 2578 to 3269 1 to 692       690/722
(95 %)
4 diff
(99.5 %id)
CD635729   MYO18AandTIAF1.a 2663 to 3268 639 to 30       608/639
(95 %)
4 diff
(99.4 %id)
BF897726 marrow MYO18AandTIAF1.a 2752 to 3172 442 to 23     Submitted on the opposite strand 420/442
(95 %)
5 diff
(98.9 %id)
CD635728   MYO18AandTIAF1.a 2819 to 3509 684 to 1       684/685
(99 %)
11 diff
(98.4 %id)
BE889927 leiomyosarcoma, uterus MYO18AandTIAF1.a 2851 to 3521 1 to 679       679/846
(80 %)
18 diff
(97.9 %id)
BX440191 brain, fetal brain MYO18AandTIAF1.a 2922 to 3616 327 to 1015       689/1020
(67 %)
23 diff
(97.8 %id)
BU431105 lymph MYO18AandTIAF1.a 2967 to 3392 8 to 433       426/433
(98 %)
7 diff
(98.4 %id)
TI_154152962   MYO18AandTIAF1.a 2967 to 3549 80 to 661       582/583
(99 %)
10 diff
(98.3 %id)
DB267891 uterus MYO18AandTIAF1.a 2980 to 3537 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
BE906143 epithelioid carcinoma, Pancreas MYO18AandTIAF1.a 3023 to 3731 707 to 1     Submitted on the opposite strand 707/707
(100 %)
8 diff
(98.9 %id)
CD635737   MYO18AandTIAF1.a 3036 to 3417 1 to 391       391/391
(100 %)
19 diff
(95.2 %id)
CD635744   MYO18AandTIAF1.a 3036 to 3700 1 to 675       675/708
(95 %)
20 diff
(97.2 %id)
CD635743   MYO18AandTIAF1.a 3045 to 3771 730 to 1       732/730
(100 %)
9 diff
(98.8 %id)
CD635740   MYO18AandTIAF1.a 3214 to 3772 1 to 558       558/558
(100 %)
6 diff
(99.0 %id)
CD635739   MYO18AandTIAF1.a 3220 to 3769 549 to 1       549/555
(98 %)
1 diff
(99.9 %id)
BI023694 marrow MYO18AandTIAF1.a 3257 to 3654 9 to 405       397/405
(98 %)
3 diff
(99.3 %id)
AI640402 adenocarcinoma, Pancreas MYO18AandTIAF1.a 3365 to 3793 428 to 1       428/428
(100 %)
10 diff
(97.7 %id)
DA390203 thalamus MYO18AandTIAF1.a 3370 to 3952 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
BM151493 leukopheresis MYO18AandTIAF1.a 3390 to 3987 599 to 1       599/601
(99 %)
5 diff
(99.2 %id)
BM153287 leukopheresis MYO18AandTIAF1.a 3438 to 3987 551 to 1       551/552
(99 %)
10 diff
(98.2 %id)
BP314992 mammary gland MYO18AandTIAF1.a 3444 to 4026 1 to 583       583/583
(100 %)
0 diff
(100 %id)
CN312473 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells MYO18AandTIAF1.a 3447 to 3769 1 to 322       322/322
(100 %)
1 diff
(99.7 %id)
CD635738   MYO18AandTIAF1.a 3471 to 3757 299 to 7       293/301
(97 %)
7 diff
(97.7 %id)
CD635741   MYO18AandTIAF1.a 3553 to 3772 1 to 219       219/219
(100 %)
5 diff
(97.8 %id)
CD635742   MYO18AandTIAF1.a 3557 to 3769 212 to 1       212/216
(98 %)
2 diff
(99.1 %id)
BE244487 leukopheresis MYO18AandTIAF1.a 3566 to 3987 422 to 1       422/422
(100 %)
2 diff
(99.6 %id)
BM146018 leukopheresis MYO18AandTIAF1.a 3589 to 3987 400 to 1       400/428
(93 %)
8 diff
(98.2 %id)
BM153233 leukopheresis MYO18AandTIAF1.a 3592 to 3987 395 to 1       395/409
(96 %)
13 diff
(96.9 %id)
AW770844 colon, juvenile granulosa tumor MYO18AandTIAF1.a 3628 to 3793 166 to 1       166/166
(100 %)
0 diff
(100 %id)
BE246750 leukopheresis MYO18AandTIAF1.a 3672 to 3987 316 to 1       316/316
(100 %)
3 diff
(99.1 %id)
BX479354   MYO18AandTIAF1.a 3722 to 4050 1 to 331       331/331
(100 %)
4 diff
(98.8 %id)
BE829995 lung_tumor MYO18AandTIAF1.a 3749 to 3969 13 to 230       218/230
(94 %)
9 diff
(96.1 %id)
BF919133 nervous_tumor MYO18AandTIAF1.a 3774 to 3886 1 to 116       116/116
(100 %)
4 diff
(96.6 %id)
BP218362 caudate nucleus MYO18AandTIAF1.a 3794 to 4383 1 to 590       590/590
(100 %)
1 diff
(99.9 %id)
BM151424 leukopheresis MYO18AandTIAF1.a 3816 to 3987 172 to 1       172/219
(78 %)
6 diff
(97.3 %id)
DA332479 hippocampus MYO18AandTIAF1.a 3846 to 4423 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
CR615876 HeLa cells Cot 25-normalized MYO18AandTIAF1.a 3847 to 5979 1 to 2133       2133/2133
(100 %)
0 diff
(100 %id)
AL555020 placenta MYO18AandTIAF1.a 3847 to 4417 1 to 571       571/653
(87 %)
5 diff
(99.3 %id)
DA808468 brain MYO18AandTIAF1.a 3900 to 4464 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
BG949101 bocio_tumor MYO18AandTIAF1.a 3914 to 4221 403 to 94       310/403
(76 %)
1 diff
(99.8 %id)
DA237597 brain MYO18AandTIAF1.a 3933 to 4506 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
BF856056 prostate_normal MYO18AandTIAF1.a 3967 to 4287 14 to 334       321/334
(96 %)
8 diff
(97.7 %id)
BF856159 prostate_normal MYO18AandTIAF1.a 3993 to 4186 1 to 191       193/191
(101 %)
11 diff
(94.3 %id)
BF766592 colon_est MYO18AandTIAF1.a 4012 to 4413 1 to 402       402/402
(100 %)
10 diff
(97.6 %id)
CD635731   MYO18AandTIAF1.a 4027 to 4171 176 to 31       146/176
(82 %)
1 diff
(99.5 %id)
CD635732   MYO18AandTIAF1.a 4027 to 4201 1 to 176       176/180
(97 %)
7 diff
(96.2 %id)
DR761105 embryonic stem MYO18AandTIAF1.a 4054 to 4226 1 to 173       173/173
(100 %)
0 diff
(100 %id)
CD635723   MYO18AandTIAF1.a 4055 to 4658 1 to 608       608/608
(100 %)
10 diff
(98.4 %id)
CD635721   MYO18AandTIAF1.a 4056 to 4657 1 to 603       603/603
(100 %)
5 diff
(99.2 %id)
CD635726   MYO18AandTIAF1.a 4056 to 4683 1 to 627       627/630
(99 %)
10 diff
(98.5 %id)
DA203925 brain MYO18AandTIAF1.a 4085 to 4653 2 to 571   capped   570/570
(100 %)
3 diff
(99.5 %id)
BM469508 embryonal carcinoma, cell line, testis MYO18AandTIAF1.a 4097 to 4858 34 to 803       770/1111
(69 %)
32 diff
(97.2 %id)
BF757421 colon MYO18AandTIAF1.a 4122 to 4376 1 to 255       255/255
(100 %)
3 diff
(98.9 %id)
BP352209   MYO18AandTIAF1.a 4188 to 4768 1 to 581       581/581
(100 %)
4 diff
(99.4 %id)
DA099513 cerebellum MYO18AandTIAF1.a 4190 to 4756 2 to 576   capped   575/575
(100 %)
8 diff
(98.7 %id)
DA113213 cerebellum MYO18AandTIAF1.a 4190 to 4781 2 to 593   capped   592/592
(100 %)
1 diff
(99.9 %id)
BG823557 adenocarcinoma cell line, colon MYO18AandTIAF1.a 4190 to 4819 1 to 631       631/631
(100 %)
4 diff
(99.4 %id)
DA110249 cerebellum MYO18AandTIAF1.a 4193 to 4730 2 to 542   capped   541/541
(100 %)
5 diff
(99.1 %id)
AA315254 colon MYO18AandTIAF1.a 4198 to 4583 1 to 386       386/386
(100 %)
1 diff
(99.8 %id)
DB234878 trachea MYO18AandTIAF1.a 4205 to 4786 2 to 583   capped   582/582
(100 %)
2 diff
(99.7 %id)
DB267306 uterus MYO18AandTIAF1.a 4208 to 4797 2 to 591   capped   590/590
(100 %)
1 diff
(99.9 %id)
DA257207 caudate nucleus MYO18AandTIAF1.a 4216 to 4763 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
BP284924 lung MYO18AandTIAF1.a 4268 to 4850 1 to 582       582/582
(100 %)
9 diff
(98.5 %id)
DB089176 testis MYO18AandTIAF1.a 4272 to 4723 2 to 453   capped   452/452
(100 %)
1 diff
(99.8 %id)
BX370510   MYO18AandTIAF1.a 4320 to 5107 6 to 793       790/925
(85 %)
45 diff
(95.2 %id)
BQ421880 embryonal carcinoma, cell line, testis MYO18AandTIAF1.a 4323 to 5006 1 to 685       685/884
(77 %)
9 diff
(99.0 %id)
BG336199 choriocarcinoma, placenta MYO18AandTIAF1.a 4351 to 4819 1 to 470       470/470
(100 %)
2 diff
(99.6 %id)
ES310693 scalp interfollicular dermis, skin MYO18AandTIAF1.a 4370 to 4772 1 to 403       403/403
(100 %)
2 diff
(99.6 %id)
BE732332 choriocarcinoma, placenta MYO18AandTIAF1.a 4371 to 4799 1 to 429       429/429
(100 %)
1 diff
(99.8 %id)
BG747360 adenocarcinoma cell line, colon MYO18AandTIAF1.a 4378 to 4819 1 to 444       444/444
(100 %)
7 diff
(98.5 %id)
BE280840 choriocarcinoma, placenta MYO18AandTIAF1.a 4379 to 4799 1 to 421       421/421
(100 %)
1 diff
(99.8 %id)
BF576514 muscle (skeletal) MYO18AandTIAF1.a 4382 to 5006 1 to 631       631/979
(64 %)
64 diff
(93.5 %id)
BU844939 ovary, teratocarcinoma, cell line MYO18AandTIAF1.a 4385 to 5255 1 to 875       875/917
(95 %)
20 diff
(97.9 %id)
BU859463 ovary, teratocarcinoma, cell line MYO18AandTIAF1.a 4385 to 5232 1 to 865       865/876
(98 %)
31 diff
(96.5 %id)
AA247784   MYO18AandTIAF1.a 4411 to 4599 1 to 189       189/189
(100 %)
3 diff
(98.5 %id)
BX329292   MYO18AandTIAF1.a 4418 to 5306 892 to 4       889/892
(99 %)
5 diff
(99.5 %id)
DA299428 hippocampus MYO18AandTIAF1.a 4432 to 4981 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
AA111871 muscle, skeletal muscle MYO18AandTIAF1.a 4439 to 4809 1 to 374       374/374
(100 %)
5 diff
(98.7 %id)
CD579800 brain MYO18AandTIAF1.a 4446 to 4966 1 to 521       521/522
(99 %)
4 diff
(99.3 %id)
CD635724   MYO18AandTIAF1.a 4551 to 5283 729 to 1       729/729
(100 %)
3 diff
(99.6 %id)
BE838116 prostate_normal MYO18AandTIAF1.a 4565 to 4921 77 to 434       358/434
(82 %)
6 diff
(98.7 %id)
BE838108 prostate_normal MYO18AandTIAF1.a 4578 to 4947 1 to 371       371/371
(100 %)
8 diff
(97.9 %id)
BI021897 marrow MYO18AandTIAF1.a 4617 to 4992 376 to 4       373/376
(99 %)
1 diff
(99.8 %id)
CD635722   MYO18AandTIAF1.a 4627 to 5283 654 to 1       654/684
(95 %)
9 diff
(98.7 %id)
BM456989 embryonal carcinoma, cell line, testis MYO18AandTIAF1.a 4680 to 5578 1 to 906       906/1041
(87 %)
21 diff
(98.0 %id)
DA777125 brain MYO18AandTIAF1.a 4685 to 5246 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
BQ058479 lymph, lymphoma, cell line MYO18AandTIAF1.a 4691 to 5569 1 to 879       879/996
(88 %)
6 diff
(99.4 %id)
AL134760 brain MYO18AandTIAF1.a 4694 to 5374 1 to 681       681/681
(100 %)
0 diff
(100 %id)
CD635725   MYO18AandTIAF1.a 4713 to 5292 584 to 3       582/584
(99 %)
3 diff
(99.5 %id)
BQ645206 hepatocellular carcinoma, cell line, Liver MYO18AandTIAF1.a 4776 to 5705 20 to 949       930/972
(95 %)
15 diff
(98.5 %id)
BQ652375 hepatocellular carcinoma, cell line, Liver MYO18AandTIAF1.a 4776 to 5368 15 to 607       593/932
(63 %)
13 diff
(98.7 %id)
BQ648993 hepatocellular carcinoma, cell line, Liver MYO18AandTIAF1.a 4776 to 5555 15 to 799       785/875
(89 %)
16 diff
(98.2 %id)
DA023636   MYO18AandTIAF1.a 4778 to 5347 2 to 572   capped   571/572
(99 %)
3 diff
(99.5 %id)
BQ650206 hepatocellular carcinoma, cell line, Liver MYO18AandTIAF1.a 4780 to 5706 1 to 937       937/941
(99 %)
20 diff
(97.9 %id)
BQ648799 hepatocellular carcinoma, cell line, Liver MYO18AandTIAF1.a 4780 to 5568 1 to 790       790/934
(84 %)
12 diff
(98.8 %id)
BQ644444 hepatocellular carcinoma, cell line, Liver MYO18AandTIAF1.a 4780 to 5675 1 to 906       906/908
(99 %)
15 diff
(98.4 %id)
BQ645066 hepatocellular carcinoma, cell line, Liver MYO18AandTIAF1.a 4780 to 5701 1 to 923       923/923
(100 %)
29 diff
(96.9 %id)
BG286399 bladder, transitional cell papilloma, cell line MYO18AandTIAF1.a 4782 to 5006 1 to 227       227/440
(51 %)
4 diff
(99.1 %id)
DA506442 brain MYO18AandTIAF1.a 4790 to 5353 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BE700032 nervous_normal MYO18AandTIAF1.a 4816 to 5068 253 to 1       253/253
(100 %)
1 diff
(99.7 %id)
BQ962332 epithelioid carcinoma cell line, Pancreas MYO18AandTIAF1.a 4840 to 5703 1 to 870       870/881
(98 %)
23 diff
(97.4 %id)
BU931449 ovary, teratocarcinoma, cell line MYO18AandTIAF1.a 4853 to 5438 1 to 593       593/797
(74 %)
21 diff
(97.4 %id)
DA443071 tongue, tumor tissue MYO18AandTIAF1.a 4933 to 5489 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
BI042996 ovary MYO18AandTIAF1.a 4953 to 5344 392 to 1       392/392
(100 %)
12 diff
(97.0 %id)
BI043090 ovary MYO18AandTIAF1.a 4953 to 5344 392 to 1       392/392
(100 %)
12 diff
(97.0 %id)
BG333555 melanotic melanoma, skin MYO18AandTIAF1.a 4986 to 5707 1 to 720       720/841
(85 %)
9 diff
(99.0 %id)
BE315436 adenocarcinoma cell line, ovary MYO18AandTIAF1.a 4994 to 5535 1 to 546       546/547
(99 %)
5 diff
(99.1 %id)
BP345876 synovial membrane MYO18AandTIAF1.a 4997 to 5569 1 to 573       573/581
(98 %)
0 diff
(100 %id)
BP299047   MYO18AandTIAF1.a 5005 to 5583 1 to 581       581/581
(100 %)
6 diff
(99.0 %id)
BP250338 hippocampus MYO18AandTIAF1.a 5020 to 5599 1 to 580       580/582
(99 %)
6 diff
(99.0 %id)
BP202945 coronary artery MYO18AandTIAF1.a 5021 to 5596 1 to 576       576/576
(100 %)
2 diff
(99.7 %id)
BG825965 muscle, rhabdomyosarcoma MYO18AandTIAF1.a 5069 to 5787 1 to 725       725/730
(99 %)
13 diff
(98.3 %id)
BI114579 muscle, rhabdomyosarcoma MYO18AandTIAF1.a 5069 to 5653 1 to 590       590/590
(100 %)
14 diff
(97.7 %id)
BI027445 marrow MYO18AandTIAF1.a 5104 to 5430 330 to 8       323/350
(92 %)
1 diff
(99.8 %id)
AL577627 placenta MYO18AandTIAF1.a 5110 to 5979 859 to 1       859/859
(100 %)
19 diff
(97.8 %id)
CD674439 eye, lens MYO18AandTIAF1.a 5136 to 5778 1 to 643       643/643
(100 %)
0 diff
(100 %id)
BG679102 skin, squamous cell carcinoma MYO18AandTIAF1.a 5178 to 5947 1 to 772       772/773
(99 %)
3 diff
(99.7 %id)
BE174510 head_neck MYO18AandTIAF1.a 5182 to 5694 529 to 17     Submitted on the opposite strand 513/532
(96 %)
0 diff
(100 %id)
AA341652 Kidney MYO18AandTIAF1.a 5184 to 5454 1 to 270       270/270
(100 %)
1 diff
(99.7 %id)
BF847361 lung_normal MYO18AandTIAF1.a 5207 to 5534 1 to 331       328/343
(95 %)
9 diff
(97.4 %id)
BF847383 lung_normal MYO18AandTIAF1.a 5210 to 5534 1 to 325       325/337
(96 %)
2 diff
(99.5 %id)
BI028124 marrow MYO18AandTIAF1.a 5258 to 5429 1 to 172       172/181
(95 %)
4 diff
(97.8 %id)
BF934890 nervous_tumor MYO18AandTIAF1.a 5261 to 5629 1 to 369       369/369
(100 %)
1 diff
(99.8 %id)
DB268462 uterus MYO18AandTIAF1.a 5292 to 5848 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
BF034521 adenocarcinoma, ovary MYO18AandTIAF1.a 5306 to 5999 1 to 695       695/696
(99 %)
6 diff
(99.2 %id)
CN312472 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells MYO18AandTIAF1.a 5318 to 6009 1 to 692       692/692
(100 %)
2 diff
(99.8 %id)
BG119373 adenocarcinoma, cell line, Liver MYO18AandTIAF1.a 5338 to 6036 1 to 696       696/1009
(68 %)
8 diff
(99.3 %id)
DA187108 amygdala MYO18AandTIAF1.a 5340 to 5870 2 to 534   capped   533/533
(100 %)
5 diff
(99.1 %id)
BP250495 hippocampus MYO18AandTIAF1.a 5345 to 5926 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
AW392891 stomach MYO18AandTIAF1.a 5368 to 5892 85 to 612       528/612
(86 %)
11 diff
(98.3 %id)
TI_154105266   MYO18AandTIAF1.a 5377 to 6076 766 to 68   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 699/769
(90 %)
2 diff
(99.8 %id)
BF738188 bladder_tumor MYO18AandTIAF1.a 5405 to 5771 367 to 1     Submitted on the opposite strand 367/367
(100 %)
2 diff
(99.5 %id)
BP366914 thymus MYO18AandTIAF1.a 5407 to 5986 1 to 580       580/580
(100 %)
6 diff
(99.0 %id)
CA446539 Chondrosarcoma, Left Pubic Bone MYO18AandTIAF1.a 5408 to 6076 670 to 3   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 668/670
(99 %)
1 diff
(99.9 %id)
BF900122 marrow MYO18AandTIAF1.a 5414 to 5752 350 to 14     Submitted on the opposite strand 337/350
(96 %)
1 diff
(99.8 %id)
BF229568 colon_est MYO18AandTIAF1.a 5417 to 5705 1 to 284       284/308
(92 %)
12 diff
(96.2 %id)
DA270520 caudate nucleus MYO18AandTIAF1.a 5437 to 5998 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA090312 cerebellum MYO18AandTIAF1.a 5441 to 6014 2 to 575   capped   574/574
(100 %)
3 diff
(99.5 %id)
CB111745 Liver MYO18AandTIAF1.a 5441 to 6045 1 to 605       605/605
(100 %)
0 diff
(100 %id)
DA981890 synovial membrane tissue from rheumatioidarthritis MYO18AandTIAF1.a 5445 to 6008 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BP303530   MYO18AandTIAF1.a 5446 to 6026 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
DB250657 uterus MYO18AandTIAF1.a 5448 to 6024 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA150763 amygdala MYO18AandTIAF1.a 5455 to 6029 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
BI869497 adenocarcinoma, cell line, Liver MYO18AandTIAF1.a 5457 to 6012 1 to 563       563/961
(58 %)
17 diff
(98.3 %id)
TI_57228544   MYO18AandTIAF1.a 5457 to 6012 39 to 601       563/961
(58 %)
17 diff
(98.3 %id)
BM810005 astrocytoma grade IV, cell line, brain MYO18AandTIAF1.a 5460 to 6383 25 to 958       936/1145
(81 %)
41 diff
(96.5 %id)
BP345852 synovial membrane MYO18AandTIAF1.a 5467 to 6045 1 to 579       579/579
(100 %)
0 diff
(100 %id)
EL593804 epidermis, skin MYO18AandTIAF1.a 5488 to 5742 20 to 274       255/296
(86 %)
7 diff
(97.7 %id)
BE762310 denis_drash MYO18AandTIAF1.a 5495 to 5698 1 to 204       204/207
(98 %)
1 diff
(99.6 %id)
AW770853 colon, juvenile granulosa tumor MYO18AandTIAF1.a 5501 to 6059 559 to 1       559/559
(100 %)
1 diff
(99.9 %id)
BQ718431 sympathetic trunk MYO18AandTIAF1.a 5503 to 6388 1 to 893       893/914
(97 %)
29 diff
(96.9 %id)
BM856928 stomach MYO18AandTIAF1.a 5512 to 5972 1 to 460       460/460
(100 %)
1 diff
(99.8 %id)
BF764931 colon_est MYO18AandTIAF1.a 5574 to 5872 299 to 1     Submitted on the opposite strand 299/299
(100 %)
4 diff
(98.7 %id)
BG831299 epithelioid carcinoma cell line, Pancreas MYO18AandTIAF1.a 5617 to 6201 1 to 586       586/969
(60 %)
8 diff
(99.2 %id)
BG830880 epithelioid carcinoma cell line, Pancreas MYO18AandTIAF1.a 5617 to 6078 1 to 468       468/794
(58 %)
8 diff
(99.0 %id)
AA086436 muscle, skeletal muscle MYO18AandTIAF1.a 5647 to 6033 404 to 12       393/409
(96 %)
10 diff
(97.6 %id)
R56926   MYO18AandTIAF1.a 5650 to 5954 1 to 307       307/307
(100 %)
15 diff
(95.2 %id)
AA249383   MYO18AandTIAF1.a 5655 to 6014 1 to 355       353/357
(98 %)
20 diff
(94.4 %id)
AA249388   MYO18AandTIAF1.a 5655 to 5761 1 to 105       105/105
(100 %)
2 diff
(98.1 %id)
BF528944 anaplastic oligodendroglioma with 1p/19qloss, brain MYO18AandTIAF1.a 5656 to 6471 1 to 817       817/1010
(80 %)
35 diff
(96.6 %id)
BF197743 skin, normal, 4 pooled samples MYO18AandTIAF1.a 5677 to 6061 385 to 1       385/385
(100 %)
0 diff
(100 %id)
AW059625   MYO18AandTIAF1.a 5759 to 5822 1 to 64       64/66
(96 %)
1 diff
(98.5 %id)
BF761507 colon_est MYO18AandTIAF1.a 5783 to 5972 32 to 221       190/229
(82 %)
9 diff
(96.1 %id)
AW579250 denis_drash MYO18AandTIAF1.a 5785 to 6193 19 to 428       410/428
(95 %)
7 diff
(98.4 %id)
BQ680301 melanotic melanoma, cell line, skin MYO18AandTIAF1.a 5803 to 6076 276 to 4   AAA Submitted on the opposite strand 273/308
(88 %)
0 diff
(100 %id)
BE181430 head_neck MYO18AandTIAF1.a 5855 to 6237 384 to 3     Submitted on the opposite strand 382/384
(99 %)
0 diff
(100 %id)
AA366174 Pancreas MYO18AandTIAF1.a 5907 to 6259 1 to 357       357/357
(100 %)
6 diff
(98.4 %id)
CN312474 embryonic stem cells, DMSO-treated H9 cellline MYO18AandTIAF1.a 5989 to 6479 1 to 491       491/491
(100 %)
0 diff
(100 %id)
BU849656 ovary, teratocarcinoma, cell line MYO18AandTIAF1.a 6013 to 6878 1 to 871       871/897
(97 %)
10 diff
(98.9 %id)
BP253422 Kidney MYO18AandTIAF1.a 6059 to 6636 1 to 578       578/578
(100 %)
3 diff
(99.5 %id)
BP252037 Kidney MYO18AandTIAF1.a 6061 to 6647 1 to 587       587/587
(100 %)
0 diff
(100 %id)
CD635745   MYO18AandTIAF1.a 6089 to 6592 1 to 505       505/505
(100 %)
10 diff
(98.1 %id)
BF905988 marrow MYO18AandTIAF1.a 6101 to 6524 423 to 2     Submitted on the opposite strand 422/423
(99 %)
0 diff
(100 %id)
BX440190 brain, fetal brain MYO18AandTIAF1.a 6527 to 7577 1041 to 1       1041/1041
(100 %)
15 diff
(98.6 %id)
CD674438 eye, lens MYO18AandTIAF1.a 7096 to 7597 523 to 22   AAA   502/502
(100 %)
0 diff
(100 %id)
NM_203318.1   MYO18AandTIAF1.b 1 to 7543 1 to 7543 exact RefSeq,   7543/7546
(99 %)
5 diff
(100.0 %id)
BM856397 stomach MYO18AandTIAF1.b 5489 to 6038 1 to 550   tiling clone,   550/550
(100 %)
0 diff
(100 %id)
BI517666 pooled colon, kidney, stomach MYO18AandTIAF1.b 5500 to 6429 1 to 923       923/976
(94 %)
33 diff
(96.7 %id)
TI_45236568   MYO18AandTIAF1.b 5500 to 6429 67 to 989       923/1042
(88 %)
39 diff
(96.3 %id)
DA137583 alzheimer cortex MYO18AandTIAF1.b 5525 to 6073 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
BQ430532 embryonal carcinoma, cell line, testis MYO18AandTIAF1.b 5566 to 6399 1 to 850       850/857
(99 %)
19 diff
(97.8 %id)
DA942500 Spleen MYO18AandTIAF1.b 5590 to 6187 2 to 599   capped   598/598
(100 %)
0 diff
(100 %id)
DA133267 alzheimer cortex MYO18AandTIAF1.b 5647 to 6185 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
AF252258 peripheral blood MYO18AandTIAF1.b 5703 to 7527 1 to 1825   tiling clone,   1825/1825
(100 %)
0 diff
(100 %id)
BG258182 embryonal carcinoma, cell line, testis MYO18AandTIAF1.b 5722 to 6505 1 to 775       775/802
(96 %)
37 diff
(95.4 %id)
BF925266 nervous_tumor MYO18AandTIAF1.b 5751 to 6221 479 to 1     Submitted on the opposite strand 479/479
(100 %)
31 diff
(93.6 %id)
BM048273 carcinoma, cell line, Prostate MYO18AandTIAF1.b 5769 to 6291 1 to 523       523/523
(100 %)
0 diff
(100 %id)
BU543540 carcinoma, cell line, Prostate MYO18AandTIAF1.b 5771 to 6561 1 to 805       805/871
(92 %)
16 diff
(98.2 %id)
DA490764 brain MYO18AandTIAF1.b 5773 to 6311 2 to 540   capped   539/539
(100 %)
2 diff
(99.7 %id)
TI_57229053   MYO18AandTIAF1.b 5806 to 6466 80 to 739       660/662
(99 %)
3 diff
(99.6 %id)
BI869589 adenocarcinoma, cell line, Liver MYO18AandTIAF1.b 5807 to 6466 1 to 659       659/661
(99 %)
3 diff
(99.6 %id)
BF926557 nervous_tumor MYO18AandTIAF1.b 5836 to 6245 428 to 21     Submitted on the opposite strand 408/428
(95 %)
0 diff
(100 %id)
CD635747   MYO18AandTIAF1.b 5851 to 6540 8 to 698       691/698
(98 %)
14 diff
(98.0 %id)
CA455191   MYO18AandTIAF1.b 6130 to 6937 1 to 808       808/857
(94 %)
1 diff
(99.9 %id)
BE883111 leiomyosarcoma, uterus MYO18AandTIAF1.b 6134 to 6902 1 to 769       769/836
(91 %)
39 diff
(95.4 %id)
BC047669 Skin, melanotic melanoma. MYO18AandTIAF1.b 6142 to 7527 1 to 1386   available from MGC, AAA   1386/1386
(100 %)
0 diff
(100 %id)
BQ229837 melanotic melanoma, skin MYO18AandTIAF1.b 6144 to 6940 1 to 797       797/830
(96 %)
4 diff
(99.6 %id)
CB129854 Liver MYO18AandTIAF1.b 6161 to 6681 1 to 521       521/521
(100 %)
0 diff
(100 %id)
R73223 breast MYO18AandTIAF1.b 6168 to 6375 1 to 207       207/207
(100 %)
7 diff
(96.7 %id)
AW801067 uterus MYO18AandTIAF1.b 6193 to 6647 1 to 454       454/469
(96 %)
6 diff
(98.8 %id)
AW891182 nervous_tumor MYO18AandTIAF1.b 6194 to 6385 192 to 5       188/200
(94 %)
0 diff
(100 %id)
BE764630 nervous_tumor MYO18AandTIAF1.b 6194 to 6405 211 to 1       211/215
(98 %)
9 diff
(95.9 %id)
BE764655 nervous_tumor MYO18AandTIAF1.b 6194 to 6664 484 to 13       472/488
(96 %)
0 diff
(100 %id)
BF815789 colon_ins MYO18AandTIAF1.b 6194 to 6604 7 to 414       408/414
(98 %)
6 diff
(98.6 %id)
CX760337 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass MYO18AandTIAF1.b 6201 to 6939 1 to 735     Submitted on the opposite strand 735/849
(86 %)
11 diff
(98.8 %id)
BE779317 eye, retinoblastoma MYO18AandTIAF1.b 6204 to 6864 1 to 666       666/756
(88 %)
29 diff
(96.2 %id)
BI034782 nervous_normal MYO18AandTIAF1.b 6219 to 6682 1 to 462       462/462
(100 %)
8 diff
(98.3 %id)
TI_149315929   MYO18AandTIAF1.b 6237 to 6828 673 to 81       593/1047
(56 %)
0 diff
(100 %id)
CB321780 lung, Primary Lung Cystic Fibrosis EpithelialCells MYO18AandTIAF1.b 6237 to 6828 616 to 24       593/630
(94 %)
0 diff
(100 %id)
BC131561 PCR rescued clones MYO18AandTIAF1.b 6242 to 7251 1 to 1010       1010/1010
(100 %)
0 diff
(100 %id)
BC131586 PCR rescued clones MYO18AandTIAF1.b 6242 to 7251 1010 to 1     Submitted on the opposite strand 1010/1010
(100 %)
0 diff
(100 %id)
CU443362 epidermis MYO18AandTIAF1.b 6245 to 6779 554 to 19     Submitted on the opposite strand 536/587
(91 %)
0 diff
(100 %id)
CU448293 epidermis MYO18AandTIAF1.b 6245 to 6713 34 to 502       469/502
(93 %)
6 diff
(98.9 %id)
CU455634 epidermis MYO18AandTIAF1.b 6245 to 6783 559 to 21     Submitted on the opposite strand 539/592
(91 %)
0 diff
(100 %id)
BG981273 colon_normal MYO18AandTIAF1.b 6285 to 6684 1 to 398       398/398
(100 %)
10 diff
(97.5 %id)
BG998419 head_neck MYO18AandTIAF1.b 6288 to 6704 439 to 15       425/439
(96 %)
0 diff
(100 %id)
BQ650633 hepatocellular carcinoma, cell line, Liver MYO18AandTIAF1.b 6294 to 7060 9 to 781       773/920
(84 %)
6 diff
(99.4 %id)
BU839435 hepatocellular carcinoma, cell line, Liver MYO18AandTIAF1.b 6298 to 7134 1 to 847       847/898
(94 %)
16 diff
(98.3 %id)
AA342099 Spleen MYO18AandTIAF1.b 6310 to 6497 1 to 188       188/188
(100 %)
2 diff
(99.0 %id)
DN990413 brain, whole brain MYO18AandTIAF1.b 6323 to 6872 9 to 558       550/558
(98 %)
9 diff
(98.4 %id)
AA339528 brain MYO18AandTIAF1.b 6369 to 6593 1 to 225       225/225
(100 %)
4 diff
(98.3 %id)
AW801625 uterus MYO18AandTIAF1.b 6371 to 6717 351 to 5       347/351
(98 %)
0 diff
(100 %id)
BQ941730 epidermoid carcinoma, cell line, lung MYO18AandTIAF1.b 6393 to 7240 1 to 859       859/919
(93 %)
23 diff
(97.5 %id)
BU191933 embryonal carcinoma, cell line, testis MYO18AandTIAF1.b 6464 to 7258 1 to 798       798/922
(86 %)
20 diff
(97.9 %id)
BC058075 Uterus, leiomyosarcoma MYO18AandTIAF1.b 6472 to 7527 17 to 1072   available from MGC, AAA   1056/1056
(100 %)
3 diff
(99.8 %id)
BM464412 leiomyosarcoma, uterus MYO18AandTIAF1.b 6476 to 7322 1 to 851   available from MGC,   851/1105
(77 %)
38 diff
(96.6 %id)
AA372000 pituitary gland MYO18AandTIAF1.b 6482 to 6807 1 to 326       326/326
(100 %)
0 diff
(100 %id)
TI_154110297   MYO18AandTIAF1.b 6584 to 7527 996 to 73   AAA   924/963
(95 %)
16 diff
(98.4 %id)
BG823353 adenocarcinoma cell line, colon MYO18AandTIAF1.b 6597 to 7302 1 to 706       706/706
(100 %)
5 diff
(99.3 %id)
AJ708147 heart MYO18AandTIAF1.b 6625 to 7079 20 to 474       455/474
(95 %)
6 diff
(98.8 %id)
TI_57228997   MYO18AandTIAF1.b 6625 to 7260 55 to 691       637/637
(100 %)
7 diff
(99.0 %id)
BI869699 adenocarcinoma, cell line, Liver MYO18AandTIAF1.b 6626 to 7260 1 to 636       636/636
(100 %)
7 diff
(98.9 %id)
BI092916 cervix MYO18AandTIAF1.b 6627 to 7307 1 to 680       680/854
(79 %)
6 diff
(99.3 %id)
TI_154113017   MYO18AandTIAF1.b 6632 to 7527 979 to 95   AAA   885/959
(92 %)
18 diff
(98.2 %id)
BG982814 colon_normal MYO18AandTIAF1.b 6638 to 7203 1 to 568       568/568
(100 %)
7 diff
(98.8 %id)
AV656203 corresponding non cancerous liver tissue MYO18AandTIAF1.b 6639 to 7043 1 to 406     Submitted on the opposite strand 406/407
(99 %)
31 diff
(92.4 %id)
BQ308897 breast MYO18AandTIAF1.b 6676 to 6995 349 to 34       316/352
(89 %)
0 diff
(100 %id)
TI_149301679   MYO18AandTIAF1.b 6680 to 7527 921 to 83   AAA   839/970
(86 %)
14 diff
(98.6 %id)
Z25133 leg muscle, skeletal muscle MYO18AandTIAF1.b 6691 to 7026 1 to 336       336/336
(100 %)
5 diff
(98.6 %id)
BG002643 placenta_normal MYO18AandTIAF1.b 6701 to 7036 347 to 13       335/365
(91 %)
0 diff
(100 %id)
BF838735 head_neck MYO18AandTIAF1.b 6706 to 7036 1 to 336       336/347
(96 %)
11 diff
(96.9 %id)
BE740803 adenocarcinoma cell line, ovary MYO18AandTIAF1.b 6707 to 7365 1 to 666       666/708
(94 %)
13 diff
(98.2 %id)
AA306339   MYO18AandTIAF1.b 6720 to 7131 1 to 412       412/412
(100 %)
0 diff
(100 %id)
BF834770 head_neck MYO18AandTIAF1.b 6722 to 7128 1 to 404       404/404
(100 %)
8 diff
(98.1 %id)
CD635748   MYO18AandTIAF1.b 6729 to 7412 686 to 6       681/686
(99 %)
0 diff
(100 %id)
R48362 breast MYO18AandTIAF1.b 6737 to 7132 1 to 404   fully sequenced,   404/404
(100 %)
14 diff
(96.6 %id)
AF105277 breast MYO18AandTIAF1.b 6738 to 7527 9 to 798   AAA   790/798
(98 %)
6 diff
(99.3 %id)
BX106548 breast MYO18AandTIAF1.b 6738 to 7527 1 to 791   AAA   791/791
(100 %)
4 diff
(99.5 %id)
BG754681 B-cells, primary B-cells from tonsils (cell line) MYO18AandTIAF1.b 6741 to 7486 1 to 746       746/746
(100 %)
9 diff
(98.8 %id)
TI_149301182   MYO18AandTIAF1.b 6744 to 7527 843 to 69   AAA   775/921
(84 %)
16 diff
(98.3 %id)
CD635746   MYO18AandTIAF1.b 6745 to 7412 671 to 7       665/671
(99 %)
0 diff
(100 %id)
TI_149312831   MYO18AandTIAF1.b 6756 to 7527 858 to 87   AAA   772/995
(77 %)
2 diff
(99.8 %id)
CA448050 Chondrosarcoma, Left Pubic Bone MYO18AandTIAF1.b 6764 to 7527 779 to 19   AAA   761/761
(100 %)
4 diff
(99.5 %id)
BU844716 ovary, teratocarcinoma, cell line MYO18AandTIAF1.b 6771 to 7525 1 to 756       756/763
(99 %)
5 diff
(99.4 %id)
CD742987 Alveolar Macrophage, lung MYO18AandTIAF1.b 6775 to 7525 771 to 21       751/771
(97 %)
0 diff
(100 %id)
BM977107 lung, Primary Lung Cystic Fibrosis EpithelialCells MYO18AandTIAF1.b 6777 to 7527 763 to 19   AAA   745/745
(100 %)
8 diff
(99.0 %id)
H26559 breast MYO18AandTIAF1.b 6783 to 7141 1 to 360   fully sequenced,   360/360
(100 %)
2 diff
(99.5 %id)
CB850570 lung, Primary Lung Cystic Fibrosis EpithelialCells MYO18AandTIAF1.b 6806 to 7527 736 to 19   AAA   718/726
(98 %)
3 diff
(99.6 %id)
BM978373 lung MYO18AandTIAF1.b 6807 to 7527 739 to 19   AAA   721/721
(100 %)
1 diff
(99.9 %id)
F00392 leg muscle, skeletal muscle MYO18AandTIAF1.b 6813 to 7080 267 to 1       267/267
(100 %)
1 diff
(99.7 %id)
BQ005000 Chondrosarcoma, Left Pelvis MYO18AandTIAF1.b 6819 to 7529 728 to 19   AAA   710/710
(100 %)
3 diff
(99.6 %id)
FN143426 breast carcinoma MYO18AandTIAF1.b 6826 to 6920 92 to 1     Submitted on the opposite strand 92/92
(100 %)
4 diff
(95.7 %id)
TI_154116017   MYO18AandTIAF1.b 6826 to 7527 768 to 76   AAA   693/781
(88 %)
33 diff
(95.8 %id)
BF342495 brain, glioblastoma with EGFR amplification MYO18AandTIAF1.b 6827 to 7527 1 to 695   AAA   695/695
(100 %)
11 diff
(98.5 %id)
BF801829 colon_ins MYO18AandTIAF1.b 6846 to 7306 481 to 20     Submitted on the opposite strand 462/481
(96 %)
0 diff
(100 %id)
BM712243 eye, lens MYO18AandTIAF1.b 6871 to 7377 1 to 507       507/507
(100 %)
0 diff
(100 %id)
T56989 fetal spleen, Spleen MYO18AandTIAF1.b 6873 to 7184 1 to 313   fully sequenced,   313/313
(100 %)
1 diff
(99.7 %id)
N89061   MYO18AandTIAF1.b 6876 to 7180 1 to 300       300/300
(100 %)
11 diff
(96.4 %id)
BG258002 embryonal carcinoma, cell line, testis MYO18AandTIAF1.b 6888 to 7529 1 to 639   AAA   639/639
(100 %)
6 diff
(99.1 %id)
TI_149299932   MYO18AandTIAF1.b 6892 to 7527 754 to 119   AAA   636/636
(100 %)
13 diff
(98.0 %id)
BM708914 eye, RPE and Choroid MYO18AandTIAF1.b 6898 to 7450 1 to 553       553/553
(100 %)
0 diff
(100 %id)
W19078 lung MYO18AandTIAF1.b 6902 to 7355 1 to 457       457/457
(100 %)
12 diff
(97.4 %id)
BQ045059 Knee, Osteoarthritic Cartilage MYO18AandTIAF1.b 6914 to 7527 631 to 19   AAA   613/613
(100 %)
3 diff
(99.6 %id)
BM694331 eye, RPE and Choroid MYO18AandTIAF1.b 6914 to 7352 1 to 439       439/439
(100 %)
0 diff
(100 %id)
BM704834 eye, RPE and Choroid MYO18AandTIAF1.b 6914 to 7284 1 to 372       372/373
(99 %)
2 diff
(99.5 %id)
CD635733   MYO18AandTIAF1.b 6919 to 7194 294 to 19       276/301
(91 %)
0 diff
(100 %id)
CD635734   MYO18AandTIAF1.b 6919 to 7194 8 to 283       276/302
(91 %)
1 diff
(99.7 %id)
BF834787 head_neck MYO18AandTIAF1.b 6931 to 7036 1 to 107       107/118
(90 %)
5 diff
(95.8 %id)
TI_151798098   MYO18AandTIAF1.b 6944 to 7527 87 to 670   AAA   584/589
(99 %)
6 diff
(99.0 %id)
BE857131 brain, glioblastoma (pooled) MYO18AandTIAF1.b 6951 to 7529 581 to 2       580/581
(99 %)
0 diff
(100 %id)
BM976109 lung, Primary Lung Cystic Fibrosis EpithelialCells MYO18AandTIAF1.b 6976 to 7527 570 to 19   AAA   552/552
(100 %)
13 diff
(97.7 %id)
BU737316 eye, fetal eyes MYO18AandTIAF1.b 7000 to 7527 546 to 19   AAA   528/528
(100 %)
1 diff
(99.9 %id)
EB388849 eye, optic nerve MYO18AandTIAF1.b 7017 to 7527 1 to 511   AAA   511/511
(100 %)
1 diff
(99.9 %id)
BG230592 blood, lymphocyte MYO18AandTIAF1.b 7023 to 7434 409 to 1       409/411
(99 %)
7 diff
(98.3 %id)
DB341369 testis MYO18AandTIAF1.b 7023 to 7527 506 to 1       506/506
(100 %)
1 diff
(99.9 %id)
AW193206 adenocarcinoma, Pancreas MYO18AandTIAF1.b 7026 to 7527 497 to 3       495/516
(95 %)
0 diff
(100 %id)
H46411 breast MYO18AandTIAF1.b 7030 to 7301 46 to 324       279/324
(86 %)
6 diff
(98.2 %id)
DB341270 testis MYO18AandTIAF1.b 7031 to 7529 499 to 1       499/499
(100 %)
1 diff
(99.8 %id)
AW771102 colon, juvenile granulosa tumor MYO18AandTIAF1.b 7032 to 7191 160 to 1       160/160
(100 %)
6 diff
(96.3 %id)
AA740900 germinal center B cell MYO18AandTIAF1.b 7033 to 7527 528 to 28   AAA   501/501
(100 %)
6 diff
(98.9 %id)
AW778911 colon, moderately-differentiated adenocarcinoma MYO18AandTIAF1.b 7035 to 7527 493 to 1       493/493
(100 %)
0 diff
(100 %id)
AW118176 pooled MYO18AandTIAF1.b 7040 to 7527 498 to 10       489/508
(96 %)
0 diff
(100 %id)
BE147479 head_neck MYO18AandTIAF1.b 7044 to 7324 6 to 285       280/295
(94 %)
7 diff
(97.7 %id)
BQ549134 insulinoma, Pancreas MYO18AandTIAF1.b 7049 to 7296 7 to 254   fully sequenced,   248/254
(97 %)
6 diff
(97.7 %id)
AI076350 liver and spleen MYO18AandTIAF1.b 7050 to 7527 479 to 2       478/479
(99 %)
0 diff
(100 %id)
AI160295 heart MYO18AandTIAF1.b 7053 to 7527 476 to 2       475/476
(99 %)
0 diff
(100 %id)
CA448626 Chondrosarcoma, Left Pelvis MYO18AandTIAF1.b 7055 to 7527 491 to 19   AAA   473/473
(100 %)
0 diff
(100 %id)
CA309726 Alveolar Macrophage, lung MYO18AandTIAF1.b 7055 to 7529 493 to 19   AAA   475/475
(100 %)
0 diff
(100 %id)
AI740545 pooled MYO18AandTIAF1.b 7057 to 7527 507 to 37   AAA   471/471
(100 %)
33 diff
(93.0 %id)
CB126483 Liver MYO18AandTIAF1.b 7059 to 7528 1 to 470   AAA   470/470
(100 %)
1 diff
(99.8 %id)
AI798756 pooled MYO18AandTIAF1.b 7068 to 7527 481 to 14   AAA   468/468
(100 %)
12 diff
(97.5 %id)
AA679025 liver and spleen MYO18AandTIAF1.b 7084 to 7527 445 to 1     Submitted on the opposite strand 445/445
(100 %)
2 diff
(99.6 %id)
AI912485 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus MYO18AandTIAF1.b 7089 to 7527 441 to 3       439/441
(99 %)
0 diff
(100 %id)
AA678982 pineal gland MYO18AandTIAF1.b 7090 to 7525 460 to 25       436/460
(94 %)
0 diff
(100 %id)
AA010343 heart MYO18AandTIAF1.b 7095 to 7527 434 to 1       434/434
(100 %)
1 diff
(99.8 %id)
R48263 breast MYO18AandTIAF1.b 7102 to 7526 440 to 1   fully sequenced,   440/440
(100 %)
15 diff
(96.6 %id)
AI801086 poorly differentiated adenocarcinoma withsignet ring cell features, stomach MYO18AandTIAF1.b 7104 to 7532 443 to 15   AAA   429/429
(100 %)
0 diff
(100 %id)
AI270683 poorly differentiated adenocarcinoma withsignet ring cell features, stomach MYO18AandTIAF1.b 7107 to 7527 431 to 11   AAA   421/421
(100 %)
0 diff
(100 %id)
H26560 breast MYO18AandTIAF1.b 7111 to 7526 421 to 3   fully sequenced,   419/421
(99 %)
12 diff
(97.2 %id)
AA402957 ovarian tumor, ovary MYO18AandTIAF1.b 7113 to 7527 428 to 14   AAA   415/415
(100 %)
0 diff
(100 %id)
BQ549619 insulinoma, Pancreas MYO18AandTIAF1.b 7114 to 7268 155 to 1   fully sequenced,   155/155
(100 %)
0 diff
(100 %id)
AW503292 lymph MYO18AandTIAF1.b 7117 to 7363 125 to 371   fully sequenced,   247/371
(66 %)
6 diff
(98.4 %id)
AA446210   MYO18AandTIAF1.b 7119 to 7519 1 to 402       402/402
(100 %)
4 diff
(99.1 %id)
AA446222   MYO18AandTIAF1.b 7119 to 7525 1 to 409       409/409
(100 %)
3 diff
(99.3 %id)
CD675379 eye, lens MYO18AandTIAF1.b 7120 to 7528 1 to 409       409/409
(100 %)
0 diff
(100 %id)
AW502275 lymph MYO18AandTIAF1.b 7123 to 7512 131 to 520       390/520
(75 %)
6 diff
(98.9 %id)
TI_154136542   MYO18AandTIAF1.b 7123 to 7527 467 to 63   AAA   405/1138
(35 %)
2 diff
(99.9 %id)
TI_154157800   MYO18AandTIAF1.b 7123 to 7527 203 to 607       405/619
(65 %)
3 diff
(99.6 %id)
TI_154159148   MYO18AandTIAF1.b 7123 to 7495 205 to 577       373/496
(75 %)
6 diff
(98.8 %id)
AA828079 colon, colon tumor MYO18AandTIAF1.b 7127 to 7532 428 to 23   AAA   406/406
(100 %)
0 diff
(100 %id)
BF899607 marrow MYO18AandTIAF1.b 7130 to 7507 12 to 389       378/396
(95 %)
3 diff
(99.3 %id)
AI360620 lymph node, lymphoma, follicular mixed small and largecell MYO18AandTIAF1.b 7134 to 7529 397 to 2       396/397
(99 %)
0 diff
(100 %id)
BX400210   MYO18AandTIAF1.b 7146 to 7529 1 to 384       384/384
(100 %)
5 diff
(98.7 %id)
AA806665 germinal center B cell MYO18AandTIAF1.b 7153 to 7527 386 to 12   AAA   375/376
(99 %)
0 diff
(100 %id)
T56988 fetal spleen, Spleen MYO18AandTIAF1.b 7154 to 7527 378 to 1   fully sequenced,   378/378
(100 %)
5 diff
(98.7 %id)
AL046057 testis MYO18AandTIAF1.b 7157 to 7527 1 to 371   AAA   371/371
(100 %)
0 diff
(100 %id)
AI208361   MYO18AandTIAF1.b 7160 to 7527 376 to 9       368/376
(97 %)
0 diff
(100 %id)
F31497 pectoral muscle (after mastectomy) MYO18AandTIAF1.b 7160 to 7447 1 to 288       288/288
(100 %)
0 diff
(100 %id)
AW474967 poorly differentiated adenocarcinoma withsignet ring cell features, stomach MYO18AandTIAF1.b 7161 to 7527 368 to 1       368/368
(100 %)
3 diff
(99.2 %id)
AA677995 liver and spleen MYO18AandTIAF1.b 7166 to 7527 365 to 4       362/365
(99 %)
0 diff
(100 %id)
BQ025790 placenta MYO18AandTIAF1.b 7167 to 7528 380 to 19   AAA   362/362
(100 %)
4 diff
(98.9 %id)
BQ447907 Knee, Osteoarthritic Cartilage MYO18AandTIAF1.b 7174 to 7535 380 to 19   AAA   362/362
(100 %)
0 diff
(100 %id)
H23967 breast MYO18AandTIAF1.b 7175 to 7526 360 to 2       359/360
(99 %)
0 diff
(100 %id)
AJ571771 pectoral muscle (after mastectomy) MYO18AandTIAF1.b 7178 to 7526 1 to 349   AAA   349/349
(100 %)
0 diff
(100 %id)
AA913657 Kidney MYO18AandTIAF1.b 7178 to 7529 369 to 18   AAA   352/352
(100 %)
0 diff
(100 %id)
AW029176 poorly differentiated adenocarcinoma withsignet ring cell features, stomach MYO18AandTIAF1.b 7178 to 7527 351 to 2       350/351
(99 %)
0 diff
(100 %id)
AA952885 pooled MYO18AandTIAF1.b 7179 to 7529 351 to 1       351/351
(100 %)
0 diff
(100 %id)
AI589142 brain, glioblastoma (pooled) MYO18AandTIAF1.b 7180 to 7527 348 to 1       348/348
(100 %)
6 diff
(98.3 %id)
AI572637 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) MYO18AandTIAF1.b 7180 to 7527 366 to 20   AAA   347/347
(100 %)
9 diff
(97.5 %id)
AI863079 brain, tumor, 5 pooled (see description) MYO18AandTIAF1.b 7180 to 7529 365 to 16   AAA   350/350
(100 %)
4 diff
(98.9 %id)
AI673567 colon, colonic mucosa from 3 patients with Crohn'sdisease MYO18AandTIAF1.b 7182 to 7527 350 to 4       347/350
(99 %)
0 diff
(100 %id)
BM544214 ovary (pool of 3) MYO18AandTIAF1.b 7185 to 7538 19 to 372   tiling clone, AAA   354/372
(95 %)
6 diff
(98.4 %id)
BM804973 ovary (pool of 3) MYO18AandTIAF1.b 7185 to 7538 14 to 367   AAA   354/367
(96 %)
6 diff
(98.4 %id)
AA035187 uterus MYO18AandTIAF1.b 7186 to 7527 1 to 345       345/346
(99 %)
4 diff
(98.9 %id)
AA884179 pooled MYO18AandTIAF1.b 7189 to 7527 343 to 5       339/343
(98 %)
0 diff
(100 %id)
AA032301 uterus MYO18AandTIAF1.b 7193 to 7527 347 to 5       343/347
(98 %)
0 diff
(100 %id)
T32365 Spleen MYO18AandTIAF1.b 7196 to 7527 332 to 1       332/334
(99 %)
2 diff
(99.5 %id)
AA878059 pharynx, squamous cell carcinoma MYO18AandTIAF1.b 7204 to 7527 328 to 5       324/328
(98 %)
0 diff
(100 %id)
D25694   MYO18AandTIAF1.b 7205 to 7527 1 to 323     Submitted on the opposite strand 323/326
(99 %)
1 diff
(99.7 %id)
AI919126 brain, glioblastoma (pooled) MYO18AandTIAF1.b 7206 to 7527 340 to 19   AAA   322/322
(100 %)
27 diff
(91.7 %id)
AA662958 normal prostate, Prostate MYO18AandTIAF1.b 7208 to 7527 321 to 2       320/321
(99 %)
0 diff
(100 %id)
BI093919 cervix MYO18AandTIAF1.b 7209 to 7527 1 to 319   AAA   319/319
(100 %)
0 diff
(100 %id)
AW050729 colon, colonic mucosa from 3 patients with Crohn'sdisease MYO18AandTIAF1.b 7222 to 7527 329 to 24   AAA   306/307
(99 %)
12 diff
(96.1 %id)
BG056044 anaplastic oligodendroglioma, brain MYO18AandTIAF1.b 7225 to 7527 308 to 6       303/308
(98 %)
0 diff
(100 %id)
AA594613 colon, colon tumor RER+ MYO18AandTIAF1.b 7242 to 7529 305 to 18   AAA   288/288
(100 %)
0 diff
(100 %id)
AI015823   MYO18AandTIAF1.b 7255 to 7527 286 to 14   AAA   273/273
(100 %)
0 diff
(100 %id)
H30396 breast MYO18AandTIAF1.b 7257 to 7501 247 to 1       247/247
(100 %)
5 diff
(98.0 %id)
AI356265 B-cell, chronic lymphotic leukemia MYO18AandTIAF1.b 7268 to 7529 297 to 36   AAA   262/262
(100 %)
8 diff
(97.0 %id)
BP392543 pancreatic islet MYO18AandTIAF1.b 7288 to 7527 1 to 241     Submitted on the opposite strand 241/241
(100 %)
1 diff
(99.6 %id)
BM685448 eye, RPE and Choroid MYO18AandTIAF1.b 7290 to 7529 8 to 247   fully sequenced, AAA   240/247
(97 %)
0 diff
(100 %id)
BG222355 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification MYO18AandTIAF1.b 7291 to 7527 257 to 21   AAA   237/237
(100 %)
4 diff
(98.4 %id)
AW182703 cervix, tumor MYO18AandTIAF1.b 7292 to 7527 240 to 5       236/240
(98 %)
0 diff
(100 %id)
BG152405 brain, glioblastoma without EGFR amplification MYO18AandTIAF1.b 7300 to 7527 229 to 2       228/229
(99 %)
0 diff
(100 %id)
T32051 brain MYO18AandTIAF1.b 7312 to 7527 216 to 1       216/216
(100 %)
0 diff
(100 %id)
H44635 breast MYO18AandTIAF1.b 7313 to 7491 183 to 4       180/183
(98 %)
0 diff
(100 %id)
BG563376 Liver MYO18AandTIAF1.b 7315 to 7527 1 to 213   AAA   213/213
(100 %)
2 diff
(99.1 %id)
AL039276 testis MYO18AandTIAF1.b 7320 to 7527 1 to 208   AAA   208/208
(100 %)
0 diff
(100 %id)
CN268132 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells MYO18AandTIAF1.b 7321 to 7527 87 to 293   AAA   207/293
(70 %)
6 diff
(98.0 %id)
BM662989 eye, RPE and Choroid MYO18AandTIAF1.b 7332 to 7529 215 to 18   fully sequenced, AAA   198/198
(100 %)
0 diff
(100 %id)
AW576350 lymph MYO18AandTIAF1.b 7333 to 7527 212 to 18   fully sequenced, AAA   195/195
(100 %)
0 diff
(100 %id)
AW148893 Kidney, renal cell tumor MYO18AandTIAF1.b 7334 to 7529 196 to 1       196/196
(100 %)
0 diff
(100 %id)
AI422485 brain, glioblastoma (pooled) MYO18AandTIAF1.b 7340 to 7527 190 to 3       188/190
(98 %)
0 diff
(100 %id)
F34989 pectoral muscle (after mastectomy) MYO18AandTIAF1.b 7345 to 7519 1 to 172       172/172
(100 %)
5 diff
(97.1 %id)
AA907175 carcinoid, lung MYO18AandTIAF1.b 7346 to 7527 191 to 10       182/191
(95 %)
0 diff
(100 %id)
AA927080 pooled MYO18AandTIAF1.b 7360 to 7527 169 to 1       169/169
(100 %)
3 diff
(98.3 %id)
BU164309 embryonal carcinoma, cell line, testis MYO18AandTIAF1.b 7369 to 7527 1 to 159   AAA   159/159
(100 %)
0 diff
(100 %id)
AA887405 carcinoid, lung MYO18AandTIAF1.b 7437 to 7527 92 to 2       91/92
(98 %)
0 diff
(100 %id)
AA480161 colon MYO18AandTIAF1.b 7448 to 7527 81 to 2       80/81
(98 %)
0 diff
(100 %id)
AI620293 poorly differentiated adenocarcinoma withsignet ring cell features, stomach MYO18AandTIAF1.b 7481 to 7527 47 to 1       47/63
(74 %)
1 diff
(98.5 %id)
CR933614 amygdala MYO18AandTIAF1.c 1 to 7492 1 to 7503 A680E G681A R682A K683E Q684A ... tiling clone, AAA   7503/7503
(100 %)
21 diff
(99.8 %id)
CB268076 adipose MYO18AandTIAF1.c 1802 to 2296 495 to 1   tiling clone, Submitted on the opposite strand 495/495
(100 %)
0 diff
(100 %id)
BC039612 Testis, embryonal carcinoma MYO18AandTIAF1.d 1 to 7522 1 to 7522 exact tiling clone, available from MGC, AAA   7522/7522
(100 %)
0 diff
(100 %id)
BQ227330 embryonal carcinoma, cell line, testis MYO18AandTIAF1.d 3 to 730 1 to 735       735/840
(87 %)
23 diff
(97.3 %id)
AB177860 brain MYO18AandTIAF1.e 1 to 6479 1 to 6479 A610V A666V tiling clone,   6479/6479
(100 %)
4 diff
(100.0 %id)
AY703984   MYO18AandTIAF1.e 1 to 6479 1 to 6479 A610V A666V     6479/6479
(100 %)
4 diff
(100.0 %id)
BQ221234 embryonal carcinoma, cell line, testis MYO18AandTIAF1.e 5 to 490 1 to 487       487/1219
(39 %)
7 diff
(99.5 %id)
AK302505 testis MYO18AandTIAF1.f 1 to 5293 2 to 5294 T189A K1530E D1587G tiling clone,   5294/5294
(100 %)
5 diff
(100.0 %id)
DB067775 testis MYO18AandTIAF1.f 1 to 566 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
AU140195 placenta MYO18AandTIAF1.g 1 to 764 2 to 766   tiling clone, capped   765/765
(100 %)
12 diff
(98.5 %id)
BQ710231 Spleen MYO18AandTIAF1.g 126 to 902 1 to 785   tiling clone,   785/926
(84 %)
30 diff
(96.8 %id)
AU158354 placenta MYO18AandTIAF1.g 2949 to 3451 502 to 1   tiling clone,   502/505
(99 %)
5 diff
(99.1 %id)
AK294180 amygdala MYO18AandTIAF1.h 1 to 1441 2 to 1442 exact tiling clone,   1442/1442
(100 %)
0 diff
(100 %id)
DA146505 amygdala MYO18AandTIAF1.h 1 to 558 2 to 559   capped   558/567
(98 %)
0 diff
(100 %id)
AK122870 brain MYO18AandTIAF1.i 1 to 2664 2 to 2665 exact tiling clone, available from FLJ,   2665/2665
(100 %)
1 diff
(100.0 %id)
DA519218 brain MYO18AandTIAF1.i 1 to 527 2 to 528   capped   527/527
(100 %)
0 diff
(100 %id)
DA858859 placenta MYO18AandTIAF1.j 1 to 567 2 to 568   tiling clone, capped   567/567
(100 %)
0 diff
(100 %id)
CR976243 T-Lymphocytes MYO18AandTIAF1.j 18 to 572 1 to 555       555/555
(100 %)
0 diff
(100 %id)
BM148202 leukopheresis MYO18AandTIAF1.j 32 to 545 1 to 514       514/514
(100 %)
2 diff
(99.7 %id)
DA857818 placenta MYO18AandTIAF1.j 34 to 569 2 to 537   capped   536/536
(100 %)
1 diff
(99.9 %id)
DA991346 synovial membrane tissue from rheumatioidarthritis MYO18AandTIAF1.j 34 to 597 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DB063303 testis MYO18AandTIAF1.j 34 to 567 2 to 536   capped   535/535
(100 %)
1 diff
(99.9 %id)
DB069821 testis MYO18AandTIAF1.j 34 to 583 2 to 553   capped   552/552
(100 %)
2 diff
(99.7 %id)
DB153336 thymus MYO18AandTIAF1.j 37 to 636 2 to 601 exact tiling clone, capped   600/600
(100 %)
0 diff
(100 %id)
AL119314 amygdala MYO18AandTIAF1.j 63 to 552 1 to 496       493/508
(97 %)
23 diff
(95.5 %id)
AL119315 amygdala MYO18AandTIAF1.j 63 to 526 1 to 472       472/472
(100 %)
8 diff
(98.4 %id)
CN312471 embryonic stem cells, cell lines H1, H7, andH9 MYO18AandTIAF1.k 1 to 667 1 to 667 exact tiling clone,   667/667
(100 %)
0 diff
(100 %id)
DB097210 testis MYO18AandTIAF1.l 1 to 591 2 to 592 exact tiling clone, capped   591/591
(100 %)
1 diff
(99.9 %id)
BE246790 leukopheresis MYO18AandTIAF1.l 32 to 355 1 to 324       324/324
(100 %)
6 diff
(98.2 %id)
DA110211 cerebellum MYO18AandTIAF1.m 1 to 568 2 to 570   tiling clone, capped   569/569
(100 %)
4 diff
(99.3 %id)
DA619780   MYO18AandTIAF1.m 410 to 1001 2 to 593 exact tiling clone, capped   592/592
(100 %)
0 diff
(100 %id)
DA678247   MYO18AandTIAF1.n 1 to 679 2 to 681   tiling clone, capped   680/748
(90 %)
2 diff
(99.8 %id)
BM794802 Ascites, stomach MYO18AandTIAF1.n 258 to 856 1 to 599   tiling clone,   599/599
(100 %)
0 diff
(100 %id)
DA310660 hippocampus MYO18AandTIAF1.o 1 to 600 2 to 601 exact tiling clone, capped   600/600
(100 %)
0 diff
(100 %id)
BF827842 head_normal MYO18AandTIAF1.p-u 1 to 428 1 to 427 R4G L5C Q6R R7G L8S ... tiling clone,   427/497
(85 %)
2 diff
(99.6 %id)
BF837840 head_neck MYO18AandTIAF1.p-u 300 to 685 23 to 407   tiling clone,   385/407
(94 %)
6 diff
(98.6 %id)
DA262591 caudate nucleus MYO18AandTIAF1.q 1 to 572 2 to 574   tiling clone, capped   573/573
(100 %)
1 diff
(99.9 %id)
DA284877 corpus callosum MYO18AandTIAF1.q 51 to 583 2 to 534   tiling clone, capped   533/533
(100 %)
1 diff
(99.9 %id)
BP368171 thymus MYO18AandTIAF1.q 225 to 803 1 to 579 exact     579/579
(100 %)
0 diff
(100 %id)
BU175234 embryonal carcinoma, cell line, testis MYO18AandTIAF1.q 229 to 1078 1 to 856   tiling clone,   856/874
(97 %)
24 diff
(97.3 %id)
CF141798 CNCAP(3)T-225 cell line, Prostate MYO18AandTIAF1.q 231 to 689 1 to 459       459/459
(100 %)
4 diff
(99.2 %id)
TI_154172639   MYO18AandTIAF1.q 238 to 837 80 to 678       599/599
(100 %)
10 diff
(98.4 %id)
BU181185 embryonal carcinoma, cell line, testis MYO18AandTIAF1.q 309 to 1165 1 to 869   tiling clone,   869/899
(96 %)
18 diff
(98.0 %id)
BE396242 endometrium, adenocarcinoma cell line, uterus MYO18AandTIAF1.q 331 to 951 25 to 647       623/647
(96 %)
10 diff
(98.5 %id)
AA338146 brain MYO18AandTIAF1.q 342 to 612 1 to 271       271/272
(99 %)
2 diff
(99.3 %id)
BQ548890.
matches multiple genes
insulinoma, Pancreas MYO18AandTIAF1.q 351 to 807 3 to 459     Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base), also hits gene SPTB 457/459
(99 %)
6 diff
(98.7 %id)
BF924508 nervous_tumor MYO18AandTIAF1.r-u 1 to 412 1 to 412 exact tiling clone,   412/412
(100 %)
0 diff
(100 %id)
BF923300 nervous_tumor MYO18AandTIAF1.r-u 2 to 398 15 to 411       397/411
(96 %)
6 diff
(98.6 %id)
DN930511 pooled MYO18AandTIAF1.s 1 to 322 322 to 1   tiling clone, Submitted on the opposite strand 322/322
(100 %)
1 diff
(99.7 %id)
DN930510 pooled MYO18AandTIAF1.s 69 to 381 1 to 314   tiling clone,   314/314
(100 %)
2 diff
(99.4 %id)
CF137443 lymph MYO18AandTIAF1.t 1 to 370 1 to 370 K60X tiling clone,   370/370
(100 %)
1 diff
(99.8 %id)
DA120374 cerebellum MYO18AandTIAF1.u-u 1 to 552 2 to 553   tiling clone, capped   552/552
(100 %)
0 diff
(100 %id)
DA106698 cerebellum MYO18AandTIAF1.u-u 385 to 920 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
AK124161 thymus MYO18AandTIAF1.u-u 424 to 2697 1 to 2274   tiling clone, available from FLJ,   2274/2274
(100 %)
5 diff
(99.8 %id)
DB117303 thymus MYO18AandTIAF1.u-u 425 to 1048 2 to 625   capped   624/624
(100 %)
0 diff
(100 %id)
DA329973 hippocampus MYO18AandTIAF1.u-u 528 to 1088 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BX954443   MYO18AandTIAF1.u-u 1468 to 1853 1 to 386       386/386
(100 %)
1 diff
(99.8 %id)
BG335554 choriocarcinoma, placenta MYO18AandTIAF1.u-u 1803 to 2461 1 to 660   available from MGC,   660/661
(99 %)
4 diff
(99.4 %id)
BC011938 Placenta, choriocarcinoma MYO18AandTIAF1.u-u 1804 to 2769 1 to 966   available from MGC, AAA   966/966
(100 %)
1 diff
(99.9 %id)
DR003068 fetal brain MYO18AandTIAF1.u-u 1809 to 2461 9 to 661       653/661
(98 %)
6 diff
(99.1 %id)
AK126861 amygdala MYO18AandTIAF1.u-u 1974 to 5760 1 to 3786   tiling clone, available from FLJ,   3786/3786
(100 %)
1 diff
(100.0 %id)
DA188393 amygdala MYO18AandTIAF1.u-u 1975 to 2517 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DN991971 brain, whole brain MYO18AandTIAF1.u-u 2107 to 2713 1 to 607       607/607
(100 %)
3 diff
(99.6 %id)
DB343739 thymus MYO18AandTIAF1.u-u 2135 to 2697 563 to 1       563/563
(100 %)
1 diff
(99.9 %id)
DA405811 thalamus MYO18AandTIAF1.u-u 2217 to 2716 2 to 501   capped   500/500
(100 %)
0 diff
(100 %id)
AA631766 breast MYO18AandTIAF1.u-u 2254 to 2698 451 to 8       444/451
(98 %)
0 diff
(100 %id)
DA013902 adrenal gland MYO18AandTIAF1.u-u 3096 to 3671 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
T84976 liver and spleen MYO18AandTIAF1.u-u 3112 to 3468 374 to 12     Submitted on the opposite strand 363/378
(96 %)
0 diff
(100 %id)
DA289702 hippocampus MYO18AandTIAF1.u-u 3339 to 3924 2 to 589   capped   588/588
(100 %)
2 diff
(99.7 %id)
AK054958 cerebellum MYO18AandTIAF1.u-u 3672 to 5760 1 to 2089   available from FLJ,   2089/2089
(100 %)
1 diff
(100.0 %id)
NM_004740.3   MYO18AandTIAF1.u-u 3672 to 5760 1 to 2089   RefSeq, AAA   2089/2089
(100 %)
0 diff
(100 %id)
DA060175 cerebellum MYO18AandTIAF1.u-u 3673 to 4236 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DB014190 esophageal, tumor tissue MYO18AandTIAF1.u-u 3781 to 4349 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DB178412 kidney, tumor tissue MYO18AandTIAF1.u-u 3874 to 4443 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
R89027 brain MYO18AandTIAF1.u-u 4195 to 4589 13 to 407       395/407
(97 %)
6 diff
(98.6 %id)
DB295350 adrenal gland MYO18AandTIAF1.u-u 5255 to 5760 507 to 1       507/509
(99 %)
1 diff
(99.9 %id)
DB296929 cerebellum MYO18AandTIAF1.u-u 5264 to 5760 497 to 1       497/505
(98 %)
0 diff
(100 %id)
BE243943 leukopheresis MYO18AandTIAF1.va 1 to 334 1 to 334 S39L P40X V41S P42L G43V ... tiling clone,   334/340
(98 %)
11 diff
(96.8 %id)
BM193300 leukopheresis MYO18AandTIAF1.va 1 to 326 1 to 324   tiling clone,   324/329
(98 %)
5 diff
(98.5 %id)
DB128841 thymus MYO18AandTIAF1.vb 1 to 549 2 to 551 G74W C75V G76W G78R G79R ... tiling clone, capped   550/550
(100 %)
1 diff
(99.9 %id)
DB280889 uterus MYO18AandTIAF1.vc 1 to 552 2 to 553 S95P tiling clone, capped   552/552
(100 %)
3 diff
(99.5 %id)
R58740   MYO18AandTIAF1.vd-u 1 to 112 1 to 112   tiling clone,   112/113
(99 %)
1 diff
(99.2 %id)
BF847692 lung_normal MYO18AandTIAF1.vd-u 60 to 372 1 to 313   tiling clone,   313/320
(97 %)
2 diff
(99.4 %id)
DA059802 cerebellum MYO18AandTIAF1.ve 1 to 564 2 to 566 R15X E16G L17A E18G T19D ... tiling clone, capped   565/565
(100 %)
3 diff
(99.5 %id)
R15670   MYO18AandTIAF1.vf 1 to 217 1 to 214 P10R A11P E13A R14T L15S ... tiling clone,   214/215
(99 %)
3 diff
(98.7 %id)
DB088560 testis MYO18AandTIAF1.vg-u 1 to 550 2 to 551   tiling clone, capped   550/550
(100 %)
1 diff
(99.9 %id)
DB088582 testis MYO18AandTIAF1.vg-u 1 to 541 2 to 542   capped   541/541
(100 %)
1 diff
(99.9 %id)
DB151520 thymus MYO18AandTIAF1.vg-u 27 to 607 2 to 583 S31X V60I tiling clone, capped   582/582
(100 %)
3 diff
(99.5 %id)
DA873117 Prostate MYO18AandTIAF1.vg-u 493 to 1012 2 to 519   tiling clone, capped   518/518
(100 %)
8 diff
(98.5 %id)
BI031760 marrow MYO18AandTIAF1.vh 1 to 298 1 to 298   tiling clone,   298/300
(99 %)
7 diff
(97.7 %id)
DB131988 thymus MYO18AandTIAF1.vh 81 to 632 2 to 553 L26P tiling clone, capped   552/552
(100 %)
2 diff
(99.7 %id)
CV422062 head_neck MYO18AandTIAF1.vh 217 to 521 1 to 309   tiling clone,   309/309
(100 %)
16 diff
(94.9 %id)
DB090260 testis MYO18AandTIAF1.vi-u 1 to 562 2 to 563 L39P N47G Q54R R60G D65G tiling clone, capped   562/562
(100 %)
22 diff
(96.1 %id)
BF836686 head_neck MYO18AandTIAF1.vj 1 to 339 1 to 339 exact tiling clone,   339/339
(100 %)
5 diff
(98.6 %id)
BE717368 head_neck MYO18AandTIAF1.vk 1 to 317 1 to 317 exact tiling clone,   317/327
(96 %)
2 diff
(99.4 %id)
BE816014 breast_normal MYO18AandTIAF1.vl-u 1 to 286 472 to 187 P2D C3L tiling clone,   286/516
(55 %)
0 diff
(100 %id)
AW013909   MYO18AandTIAF1.vm 1 to 261 278 to 18 exact tiling clone, AAA   261/261
(100 %)
1 diff
(99.7 %id)
AK302725 testis Gene MYO18AandTIAF1, variant not shown         Suspected internal deletion, this clone was ignored    
AK303522 thymus Gene MYO18AandTIAF1, variant not shown         Suspected internal deletion, this clone was ignored    
BF926547 nervous_tumor Gene MYO18AandTIAF1, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
BI023053 marrow Gene MYO18AandTIAF1, variant not shown         This clone was ignored    
DA175653 amygdala Gene MYO18AandTIAF1, variant not shown       capped Suspected internal deletion, this clone was ignored    
AI028489 B-cell, chronic lymphotic leukemia Gene MYO18AandTIAF1, variant not shown         Suspected internal deletion, this clone was ignored    
AI342185 lung Gene MYO18AandTIAF1, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AI363252 brain, glioblastoma (pooled) Gene MYO18AandTIAF1, variant not shown         Suspected internal deletion, this clone was ignored    
AI688169 colon Gene MYO18AandTIAF1, variant not shown         Suspected internal deletion, this clone was ignored    
BF305766 muscle, rhabdomyosarcoma Gene MYO18AandTIAF1, variant not shown         This clone was ignored    
BM922301 pooled brain, lung, testis Gene MYO18AandTIAF1, variant not shown         Suspected internal deletion, this clone was ignored    
BM922302 pooled brain, lung, testis Gene MYO18AandTIAF1, variant not shown         Suspected internal deletion, this clone was ignored    
BQ218476 large cell carcinoma, lung Gene MYO18AandTIAF1, variant not shown         This clone was ignored    
BU930982 ovary, teratocarcinoma, cell line Gene MYO18AandTIAF1, variant not shown         Suspected internal deletion, this clone was ignored    
BP287613 lung Gene MYO18AandTIAF1, variant not shown         Suspected internal deletion, this clone was ignored    
BP288089 lung Gene MYO18AandTIAF1, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
DA939546 Spleen Gene MYO18AandTIAF1, variant not shown       capped This clone was ignored    
DB333074 Spleen Gene MYO18AandTIAF1, variant not shown         This clone was ignored    
DB079461 testis Gene MYO18AandTIAF1, variant not shown       capped Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p-u, .q, .r-u, .s, .t, .u-u, .va, .vb, .vc, .vd-u, .ve, .vf, .vg-u, .vh, .vi-u, .vj, .vk, .vl-u, .vm Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI